查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2027 年全球放射性藥物市場
市場調查報告書
商品編碼
1348314

2023-2027 年全球放射性藥物市場

Global Radiopharmaceuticals Market 2023-2027
出版日期: | 出版商: TechNavio | 英文 160 Pages | 訂單完成後即時交付

價格

預計2022-2027年放射性藥物市場將成長46.1262億美元，預測期內年複合成長率為10.22%。

該研究報告包括對放射性藥物市場的總體分析、市場規模/預測、趨勢、成長促進因素、課題以及涵蓋約 25 家供應商的供應商分析。

本報告提供對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場的促進因素包括神經系統疾病罹患率上升、癌症病例增加、腫瘤市場投資增加、放射性藥物副作用最小化等。

市場範圍
基準年 2022年
結束年份 2027年
預測期 2023-2027
成長動力 加速度
2023 年與前一年同期比較 10.02%
年複合成長率 10.22%
增量 4,612,620,000 美元

這項研究將基於迴旋加速器的放射性藥物生產確定為未來年度推動放射性藥物市場成長的關鍵因素之一。此外，新興經濟體新放射性藥物的發現和開拓以及醫療基礎設施的改善將帶來巨大的市場需求。

目錄

第1章 執行摘要

  • 市場概況

第2章 市場形勢

  • 市場生態系統

第3章 市場規模

  • 市場定義
  • 區隔市場分析
  • 2022 年市場規模
  • 2022-2027年市場預測

第4章 市場規模實績

  • 2017-2021年全球放射性藥物市場
  • 2017-2021 年原產地分析
  • 2017-2021 年最終用戶區隔分析
  • 2017-2021 年區域區隔分析
  • 2017-2021 年國家區隔分析

第5章 力分析

  • 五力摘要
  • 買方議價能力
  • 供應商的議價能力
  • 新進入者的威脅
  • 替代的威脅
  • 競爭威脅
  • 市場狀況

第6章 市場區隔：依來源

  • 區隔市場
  • 比較：依來源
  • 迴旋加速器：2022-2027 年市場規模與預測
  • 核反應器：市場規模與預測 2022-2027
  • 市場機會：依產地分類

第7章 市場區隔：依最終用戶

  • 區隔市場
  • 比較：依最終用戶
  • 診斷：市場規模及2022-2027年預測
  • 治療：2022-2027年市場規模與預測
  • 市場機會：依最終用戶分類

第8章 客戶形勢

  • 客戶形勢概覽

第9章 地區形勢

  • 區域區隔
  • 區域比較
  • 北美：2022-2027 年市場規模與預測
  • 歐洲：2022-2027 年市場規模與預測
  • 亞洲：2022-2027 年市場規模與預測
  • 世界其他地區：2022-2027 年市場規模與預測
  • 美國：2022-2027 年市場規模與預測
  • 德國：2022-2027 年市場規模與預測
  • 英國：2022-2027 年市場規模與預測
  • 加拿大：2022-2027 年市場規模與預測
  • 中國：2022-2027年市場規模及預測
  • 市場機會：依地區形勢

第10章 促進因素、課題與趨勢

  • 市場促進因素
  • 市場課題
  • 促進因素和課題的影響
  • 市場趨勢

第11章供應商形勢

  • 概述
  • 供應商形勢
  • 混亂的情況
  • 產業風險

第12章供應商分析

  • 交易廠商
  • 供應商市場定位
  • Bayer AG
  • Bracco Spa
  • Cardinal Health Inc.
  • Curium Pharma
  • Eckert and Ziegler AG
  • General Electric Co.
  • IBA Radiopharma Solutions
  • Jubilant Pharma Ltd.
  • Lantheus Holdings Inc.
  • NorthStar Medical Radioisotopes LLC
  • Novartis AG
  • NTP Radioisotopes SOC Ltd.
  • PharmaLogic Holdings Corp.
  • Siemens AG
  • Sotera Health Co.

第13章附錄

Product Code: IRTNTR43963

The radiopharmaceuticals market is forecasted to grow by USD 4612.62 mn during 2022-2027, accelerating at a CAGR of 10.22% during the forecast period. The report on the radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a rising incidence of neurological disorders, growing cancer cases rising investment in the oncology market, and minimal side effects of radiopharmaceuticals.

Technavio's radiopharmaceuticals market is segmented as below:

Market Scope
Base Year2022
End Year2027
Series Year2023-2027
Growth MomentumAccelerate
YOY 202310.02%
CAGR10.22%
Incremental Value$4612.62mn

By Source

  • Cyclotrons
  • Nuclear reactors

By End-user

  • Diagnostics
  • Therapeutics

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the production of cyclotron-based radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years. Also, discovery and development of new radiopharmaceuticals and improvement in healthcare infrastructure in emerging economies will lead to sizable demand in the market.

The report on the radiopharmaceuticals market covers the following areas:

  • Radiopharmaceuticals market sizing
  • Radiopharmaceuticals market forecast
  • Radiopharmaceuticals market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radiopharmaceuticals market vendors that include Bayer AG, Bracco Spa, Cardinal Health Inc., Curium Pharma, Eckert and Ziegler AG, General Electric Co., IBA Radiopharma Solutions, Jubilant Pharma Ltd., Lantheus Holdings Inc., Mallinckrodt Plc, NorthStar Medical Radioisotopes LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Positron Corp., Radiomedix Inc., Siemens AG, Sinotau Pharmaceuticals, Telix Pharmaceuticals Ltd., and Sotera Health Co.. Also, the radiopharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Source
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global radiopharmaceuticals market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global radiopharmaceuticals market 2017 - 2021 ($ million)
  • 4.2 Source Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Source Segment 2017 - 2021 ($ million)
  • 4.3 End-user Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Source

  • 6.1 Market segments
  • Exhibit 30: Chart on Source - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Source - Market share 2022-2027 (%)
  • 6.2 Comparison by Source
  • Exhibit 32: Chart on Comparison by Source
  • Exhibit 33: Data Table on Comparison by Source
  • 6.3 Cyclotrons - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Cyclotrons - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Cyclotrons - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Cyclotrons - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Cyclotrons - Year-over-year growth 2022-2027 (%)
  • 6.4 Nuclear reactors - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Nuclear reactors - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Nuclear reactors - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Nuclear reactors - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Nuclear reactors - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Source
  • Exhibit 42: Market opportunity by Source ($ million)
  • Exhibit 43: Data Table on Market opportunity by Source ($ million)

7 Market Segmentation by End-user

  • 7.1 Market segments
  • Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
  • 7.2 Comparison by End-user
  • Exhibit 46: Chart on Comparison by End-user
  • Exhibit 47: Data Table on Comparison by End-user
  • 7.3 Diagnostics - Market size and forecast 2022-2027
  • Exhibit 48: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 50: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
  • Exhibit 51: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)
  • 7.4 Therapeutics - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Therapeutics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on Therapeutics - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on Therapeutics - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Therapeutics - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by End-user
  • Exhibit 56: Market opportunity by End-user ($ million)
  • Exhibit 57: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 61: Chart on Geographic comparison
  • Exhibit 62: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 UK - Market size and forecast 2022-2027
  • Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.10 Canada - Market size and forecast 2022-2027
  • Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.11 China - Market size and forecast 2022-2027
  • Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 99: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 103: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 104: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 105: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 106: Matrix on vendor position and classification
  • 12.3 Bayer AG
  • Exhibit 107: Bayer AG - Overview
  • Exhibit 108: Bayer AG - Business segments
  • Exhibit 109: Bayer AG - Key news
  • Exhibit 110: Bayer AG - Key offerings
  • Exhibit 111: Bayer AG - Segment focus
  • 12.4 Bracco Spa
  • Exhibit 112: Bracco Spa - Overview
  • Exhibit 113: Bracco Spa - Product / Service
  • Exhibit 114: Bracco Spa - Key offerings
  • 12.5 Cardinal Health Inc.
  • Exhibit 115: Cardinal Health Inc. - Overview
  • Exhibit 116: Cardinal Health Inc. - Business segments
  • Exhibit 117: Cardinal Health Inc. - Key news
  • Exhibit 118: Cardinal Health Inc. - Key offerings
  • Exhibit 119: Cardinal Health Inc. - Segment focus
  • 12.6 Curium Pharma
  • Exhibit 120: Curium Pharma - Overview
  • Exhibit 121: Curium Pharma - Product / Service
  • Exhibit 122: Curium Pharma - Key offerings
  • 12.7 Eckert and Ziegler AG
  • Exhibit 123: Eckert and Ziegler AG - Overview
  • Exhibit 124: Eckert and Ziegler AG - Business segments
  • Exhibit 125: Eckert and Ziegler AG - Key news
  • Exhibit 126: Eckert and Ziegler AG - Key offerings
  • Exhibit 127: Eckert and Ziegler AG - Segment focus
  • 12.8 General Electric Co.
  • Exhibit 128: General Electric Co. - Overview
  • Exhibit 129: General Electric Co. - Business segments
  • Exhibit 130: General Electric Co. - Key news
  • Exhibit 131: General Electric Co. - Key offerings
  • Exhibit 132: General Electric Co. - Segment focus
  • 12.9 IBA Radiopharma Solutions
  • Exhibit 133: IBA Radiopharma Solutions - Overview
  • Exhibit 134: IBA Radiopharma Solutions - Business segments
  • Exhibit 135: IBA Radiopharma Solutions - Key offerings
  • Exhibit 136: IBA Radiopharma Solutions - Segment focus
  • 12.10 Jubilant Pharma Ltd.
  • Exhibit 137: Jubilant Pharma Ltd. - Overview
  • Exhibit 138: Jubilant Pharma Ltd. - Product / Service
  • Exhibit 139: Jubilant Pharma Ltd. - Key offerings
  • 12.11 Lantheus Holdings Inc.
  • Exhibit 140: Lantheus Holdings Inc. - Overview
  • Exhibit 141: Lantheus Holdings Inc. - Business segments
  • Exhibit 142: Lantheus Holdings Inc. - Key offerings
  • Exhibit 143: Lantheus Holdings Inc. - Segment focus
  • 12.12 NorthStar Medical Radioisotopes LLC
  • Exhibit 144: NorthStar Medical Radioisotopes LLC - Overview
  • Exhibit 145: NorthStar Medical Radioisotopes LLC - Product / Service
  • Exhibit 146: NorthStar Medical Radioisotopes LLC - Key offerings
  • 12.13 Novartis AG
  • Exhibit 147: Novartis AG - Overview
  • Exhibit 148: Novartis AG - Business segments
  • Exhibit 149: Novartis AG - Key offerings
  • Exhibit 150: Novartis AG - Segment focus
  • 12.14 NTP Radioisotopes SOC Ltd.
  • Exhibit 151: NTP Radioisotopes SOC Ltd. - Overview
  • Exhibit 152: NTP Radioisotopes SOC Ltd. - Product / Service
  • Exhibit 153: NTP Radioisotopes SOC Ltd. - Key offerings
  • 12.15 PharmaLogic Holdings Corp.
  • Exhibit 154: PharmaLogic Holdings Corp. - Overview
  • Exhibit 155: PharmaLogic Holdings Corp. - Product / Service
  • Exhibit 156: PharmaLogic Holdings Corp. - Key offerings
  • 12.16 Siemens AG
  • Exhibit 157: Siemens AG - Overview
  • Exhibit 158: Siemens AG - Business segments
  • Exhibit 159: Siemens AG - Key news
  • Exhibit 160: Siemens AG - Key offerings
  • Exhibit 161: Siemens AG - Segment focus
  • 12.17 Sotera Health Co.
  • Exhibit 162: Sotera Health Co. - Overview
  • Exhibit 163: Sotera Health Co. - Business segments
  • Exhibit 164: Sotera Health Co. - Key offerings
  • Exhibit 165: Sotera Health Co. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 166: Inclusions checklist
  • Exhibit 167: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 168: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 169: Research methodology
  • Exhibit 170: Validation techniques employed for market sizing
  • Exhibit 171: Information sources
  • 13.5 List of abbreviations
  • Exhibit 172: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Source
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on global radiopharmaceuticals market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - Source Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Source - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Source - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Source
  • Exhibits33: Data Table on Comparison by Source
  • Exhibits34: Chart on Cyclotrons - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Cyclotrons - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Cyclotrons - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Cyclotrons - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Nuclear reactors - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Nuclear reactors - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Nuclear reactors - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Nuclear reactors - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Market opportunity by Source ($ million)
  • Exhibits43: Data Table on Market opportunity by Source ($ million)
  • Exhibits44: Chart on End-user - Market share 2022-2027 (%)
  • Exhibits45: Data Table on End-user - Market share 2022-2027 (%)
  • Exhibits46: Chart on Comparison by End-user
  • Exhibits47: Data Table on Comparison by End-user
  • Exhibits48: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
  • Exhibits49: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
  • Exhibits50: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
  • Exhibits51: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)
  • Exhibits52: Chart on Therapeutics - Market size and forecast 2022-2027 ($ million)
  • Exhibits53: Data Table on Therapeutics - Market size and forecast 2022-2027 ($ million)
  • Exhibits54: Chart on Therapeutics - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Data Table on Therapeutics - Year-over-year growth 2022-2027 (%)
  • Exhibits56: Market opportunity by End-user ($ million)
  • Exhibits57: Data Table on Market opportunity by End-user ($ million)
  • Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits61: Chart on Geographic comparison
  • Exhibits62: Data Table on Geographic comparison
  • Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits85: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits93: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Market opportunity By Geographical Landscape ($ million)
  • Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits101: Impact of drivers and challenges in 2022 and 2027
  • Exhibits102: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits103: Overview on factors of disruption
  • Exhibits104: Impact of key risks on business
  • Exhibits105: Vendors covered
  • Exhibits106: Matrix on vendor position and classification
  • Exhibits107: Bayer AG - Overview
  • Exhibits108: Bayer AG - Business segments
  • Exhibits109: Bayer AG - Key news
  • Exhibits110: Bayer AG - Key offerings
  • Exhibits111: Bayer AG - Segment focus
  • Exhibits112: Bracco Spa - Overview
  • Exhibits113: Bracco Spa - Product / Service
  • Exhibits114: Bracco Spa - Key offerings
  • Exhibits115: Cardinal Health Inc. - Overview
  • Exhibits116: Cardinal Health Inc. - Business segments
  • Exhibits117: Cardinal Health Inc. - Key news
  • Exhibits118: Cardinal Health Inc. - Key offerings
  • Exhibits119: Cardinal Health Inc. - Segment focus
  • Exhibits120: Curium Pharma - Overview
  • Exhibits121: Curium Pharma - Product / Service
  • Exhibits122: Curium Pharma - Key offerings
  • Exhibits123: Eckert and Ziegler AG - Overview
  • Exhibits124: Eckert and Ziegler AG - Business segments
  • Exhibits125: Eckert and Ziegler AG - Key news
  • Exhibits126: Eckert and Ziegler AG - Key offerings
  • Exhibits127: Eckert and Ziegler AG - Segment focus
  • Exhibits128: General Electric Co. - Overview
  • Exhibits129: General Electric Co. - Business segments
  • Exhibits130: General Electric Co. - Key news
  • Exhibits131: General Electric Co. - Key offerings
  • Exhibits132: General Electric Co. - Segment focus
  • Exhibits133: IBA Radiopharma Solutions - Overview
  • Exhibits134: IBA Radiopharma Solutions - Business segments
  • Exhibits135: IBA Radiopharma Solutions - Key offerings
  • Exhibits136: IBA Radiopharma Solutions - Segment focus
  • Exhibits137: Jubilant Pharma Ltd. - Overview
  • Exhibits138: Jubilant Pharma Ltd. - Product / Service
  • Exhibits139: Jubilant Pharma Ltd. - Key offerings
  • Exhibits140: Lantheus Holdings Inc. - Overview
  • Exhibits141: Lantheus Holdings Inc. - Business segments
  • Exhibits142: Lantheus Holdings Inc. - Key offerings
  • Exhibits143: Lantheus Holdings Inc. - Segment focus
  • Exhibits144: NorthStar Medical Radioisotopes LLC - Overview
  • Exhibits145: NorthStar Medical Radioisotopes LLC - Product / Service
  • Exhibits146: NorthStar Medical Radioisotopes LLC - Key offerings
  • Exhibits147: Novartis AG - Overview
  • Exhibits148: Novartis AG - Business segments
  • Exhibits149: Novartis AG - Key offerings
  • Exhibits150: Novartis AG - Segment focus
  • Exhibits151: NTP Radioisotopes SOC Ltd. - Overview
  • Exhibits152: NTP Radioisotopes SOC Ltd. - Product / Service
  • Exhibits153: NTP Radioisotopes SOC Ltd. - Key offerings
  • Exhibits154: PharmaLogic Holdings Corp. - Overview
  • Exhibits155: PharmaLogic Holdings Corp. - Product / Service
  • Exhibits156: PharmaLogic Holdings Corp. - Key offerings
  • Exhibits157: Siemens AG - Overview
  • Exhibits158: Siemens AG - Business segments
  • Exhibits159: Siemens AG - Key news
  • Exhibits160: Siemens AG - Key offerings
  • Exhibits161: Siemens AG - Segment focus
  • Exhibits162: Sotera Health Co. - Overview
  • Exhibits163: Sotera Health Co. - Business segments
  • Exhibits164: Sotera Health Co. - Key offerings
  • Exhibits165: Sotera Health Co. - Segment focus
  • Exhibits166: Inclusions checklist
  • Exhibits167: Exclusions checklist
  • Exhibits168: Currency conversion rates for US$
  • Exhibits169: Research methodology
  • Exhibits170: Validation techniques employed for market sizing
  • Exhibits171: Information sources
  • Exhibits172: List of abbreviations